Mobile Site ›
Print Page Email Page
Print Friendly View

Test ID: OIL28    
Interleukin 28B (IL28B) Polymorphism (rs12979860), Saliva

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Conditional

Useful For Suggests clinical disorders or settings where the test may be helpful

Predicting responsiveness of genotype 1 hepatitis C viral infections to combined pegylated-interferon and ribavirin-based therapies

This saliva-based test is especially useful for establishing the IL28B genotype in patients who received a heterologous blood transfusion, in the preceding 45 days (6 weeks) or allogeneic bone marrow transplants.

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.

 

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Polymerase Chain Reaction (PCR) Followed by 5'-Nuclease End-Point Allelic Discrimination Analysis

(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

IL28B Polymorphism Genotype, Saliva

Aliases Lists additional common names for a test, as an aid in searching

IL28
IL28B
Interleukin 28B
rs12979860